ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

Werner Kirsten, director, Fredrick Center, Dead At 67 of Heart Attack

January 1, 1993

In Brief: Seffrin’s ACS Appointment Is Official; Liotta Selected As NIH; Strategic Plan Meetings

June 12, 1992

In Brief: Durant Says He Expects Comprehensive Centers Lineup to Change With New System

December 15, 1989

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

NCI to set separate payline for R01s over $700,000.

February 13, 2004